The Ultimate Guide To Dianabol: Risks, Benefits, And Cycles

**Comprehensive Clinical Report – Testosterone Therapy for a 32‑Year‑Old Male**

| Section | Key Points |
|---------|------------|
| **Patient Profile** | • 32 y/o male
• Normal weight, no known chronic disease
• No medication or substance use reported
• Symptoms: fatigue, reduced libido, mild depression, difficulty concentrating |
| **Primary Goal** | Restore physiological testosterone levels to alleviate symptoms while minimizing adverse events |

---

## 1. Baseline Evaluation

| Test | Rationale | Target/Reference Range |
|------|-----------|------------------------|
| **Serum Total Testosterone (TT)** – morning ≥ 10:00 am, fasting | Core diagnostic measure; reflects bioactive hormone | > 300 ng/dL (≈ 10.4 nmol/L) |
| **Free Testosterone** | Useful if TT low but clinical picture ambiguous (e.g., altered SHBG) | 1–3 pg/mL |
| **Sex Hormone Binding Globulin (SHBG)** | Determines free fraction; high in obesity, hypothyroid, etc. | 20–120 nmol/L |
| **Estradiol** – if symptoms of feminization or gynecomastia | Elevated in obesity, aromatase activity |